Beaute J, Kramarz P
Euro Surveill. 2022; 27(22).
PMID: 35656833
PMC: 9164672.
DOI: 10.2807/1560-7917.ES.2022.27.22.2200430.
Sholeye A, Williams A, Loots D, van Furth A, van der Kuip M, Mason S
Front Neurol. 2022; 13:804838.
PMID: 35386409
PMC: 8978302.
DOI: 10.3389/fneur.2022.804838.
Jackson S, Kabir Z, Comiskey C
J Clin Tuberc Other Mycobact Dis. 2021; 23:100225.
PMID: 33681478
PMC: 7930366.
DOI: 10.1016/j.jctube.2021.100225.
Hayward S, Rustage K, Nellums L, van der Werf M, Noori T, Boccia D
Clin Microbiol Infect. 2020; 27(9):1347.e1-1347.e7.
PMID: 33352301
PMC: 8437049.
DOI: 10.1016/j.cmi.2020.12.006.
van Halsema C, Okhai H, Hill T, Sabin C
AIDS. 2020; 34(12):1813-1821.
PMID: 32501837
PMC: 8635262.
DOI: 10.1097/QAD.0000000000002599.
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study.
Roy R, Thee S, Blazquez-Gamero D, Falcon-Neyra L, Neth O, Noguera-Julian A
Eur Respir J. 2020; 56(1).
PMID: 32299859
PMC: 7330130.
DOI: 10.1183/13993003.02004-2019.
Tuberculosis-Related Hospitalizations in a Low-Incidence Country: A Retrospective Analysis in Two Italian Infectious Diseases Wards.
Campogiani L, Compagno M, Coppola L, Malagnino V, Maffongelli G, Saraca L
Int J Environ Res Public Health. 2019; 17(1).
PMID: 31878009
PMC: 6981912.
DOI: 10.3390/ijerph17010124.
Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011- 2016.
Cannas A, Butera O, Gualano G, Parracino M, Venditti C, Mazzarelli A
Infect Drug Resist. 2019; 12:3275-3281.
PMID: 31695446
PMC: 6805241.
DOI: 10.2147/IDR.S218744.
Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.
Karo B, Kohlenberg A, Hollo V, Duarte R, Fiebig L, Jackson S
Euro Surveill. 2019; 24(12).
PMID: 30914081
PMC: 6440580.
DOI: 10.2807/1560-7917.ES.2019.24.12.1800392.
Determinants of patient and health system delay among Italian and foreign-born patients with pulmonary tuberculosis: a multicentre cross-sectional study.
Quattrocchi A, Barchitta M, Nobile C, Prato R, Sotgiu G, Casuccio A
BMJ Open. 2018; 8(8):e019673.
PMID: 30082341
PMC: 6078265.
DOI: 10.1136/bmjopen-2017-019673.
The convergent epidemiology of tuberculosis and human cytomegalovirus infection.
Cobelens F, Nagelkerke N, Fletcher H
F1000Res. 2018; 7:280.
PMID: 29780582
PMC: 5934687.
DOI: 10.12688/f1000research.14184.2.
The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C, Pareek M, Abou Chakra C, Walji M, Makarenko I, Alabdulkarim B
Euro Surveill. 2018; 23(14).
PMID: 29637888
PMC: 5894252.
DOI: 10.2807/1560-7917.ES.2018.23.14.17-00542.
Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection.
Dobler C, Bosnic-Anticevich S, Armour C
ERJ Open Res. 2018; 4(1).
PMID: 29577042
PMC: 5864969.
DOI: 10.1183/23120541.00146-2017.
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.
Pittalis S, Piselli P, Contini S, Gualano G, Alma M, Tadolini M
PLoS One. 2017; 12(12):e0189425.
PMID: 29253014
PMC: 5734730.
DOI: 10.1371/journal.pone.0189425.
Letter to the editor: Trends in tuberculosis notification rates by country of origin in the metropolitan area of Rome, 2010 to 2015.
Sane Schepisi M, Scognamiglio P, DAmato M, Girardi E, Puro V
Euro Surveill. 2017; 22(27).
PMID: 28703099
PMC: 5508332.
DOI: 10.2807/1560-7917.ES.2017.22.27.30570.
Ending tuberculosis in risk groups in Europe: challenges from travel and population movement.
Jackson C, Abubakar I
Euro Surveill. 2017; 22(12).
PMID: 28367797
PMC: 5388128.
DOI: 10.2807/1560-7917.ES.2017.22.12.30489.